Paul Bröckelmann (@broeckelmannpj) 's Twitter Profile
Paul Bröckelmann

@broeckelmannpj

Physician Scientist @UKKoeln & @MPIAGE. Hemato-Oncology, Lymphoma, Immunotherapy. Views are mine & no advise, RT/like no endorsement. COI: bit.ly/34MaLOt

ID: 1209011263

linkhttp://innere1.uk-koeln.de calendar_today22-02-2013 15:48:53

1,1K Tweet

962 Followers

107 Following

Paul Bröckelmann (@broeckelmannpj) 's Twitter Profile Photo
Paul Bröckelmann
@broeckelmannpj

a year ago

GHSG HD21 trial results The Lancet: Unprecedented outcomes in advanced-stage cHL. PET-guided BrECADD superior to eBEACOPP: Better tolerability, higher dose density and 4y PFS 94.3%. Congrats to everyone involved - truly great international academic effort t.ly/TrZHU

GHSG HD21 trial results <a href="/TheLancet/">The Lancet</a>: Unprecedented outcomes in advanced-stage cHL. PET-guided BrECADD superior to eBEACOPP: Better tolerability, higher dose density and 4y PFS 94.3%. Congrats to everyone involved - truly great international academic effort t.ly/TrZHU